Literature DB >> 15097306

The natural history of HIV-1 infection in young Thai men after seroconversion.

Ram Rangsin1, Joseph Chiu, Chirasak Khamboonruang, Narongrid Sirisopana, Sakol Eiumtrakul, Arthur E Brown, Merlin Robb, Chris Beyrer, Cholticha Ruangyuttikarn, Lauri E Markowitz, Kenrad E Nelson.   

Abstract

The natural history and progression of HIV-1 infection in Thailand and other developing countries in Asia and Africa have not been well defined. Nevertheless, valid data are needed to evaluate the effects of interventions, which are designed to delay progression. We evaluated the progression to AIDS and death in 235 men who seroconverted during their 2 years of service in the Royal Thai Army. The men were conscripted at age 21 and seroconverted within a 6-month window during follow-up while in the military. The seroconverters were matched with men who were seronegative when discharged. Of the HIV-positive men, 156 (66.4%) were alive, 77 (32.8%) had died, and 2 (0.8%) could not be located 5-7 years after their seroconversion and discharge from the military. The 5-year survival rate was 82.3%; the median times to clinical AIDS and a CD4 cell count of <200/microL was 7.4 years and 6.9 years, respectively. The mortality rate was 56.3 deaths per 1000 patient-years for HIV-positive men and 6.1 deaths per 1000 patient-years for HIV-negative men. Our data suggest a more rapid progression to AIDS and death after HIV-1 infection in young men in Thailand than has been reported for similarly aged cohorts in developed countries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15097306     DOI: 10.1097/00126334-200405010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

1.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

2.  The importance of militaries from developing countries in global infectious disease surveillance.

Authors:  Jean-Paul Chretien; David L Blazes; Rodney L Coldren; Michael D Lewis; Jariyanart Gaywee; Khunakorn Kana; Narongrid Sirisopana; Victor Vallejos; Carmen C Mundaca; Silvia Montano; Gregory J Martin; Joel C Gaydos
Journal:  Bull World Health Organ       Date:  2007-03       Impact factor: 9.408

3.  The welfare costs of HIV/AIDS in eastern Europe: an empirical assessment using the economic value-of-life approach.

Authors:  Julia Fimpel; Michael Stolpe
Journal:  Eur J Health Econ       Date:  2009-08-05

4.  Patient-Initiated Repackaging of Antiretroviral Therapy, Viral Suppression and Drug Resistance.

Authors:  Habib O Ramadhani; Charles Muiruri; Venance P Maro; Balthazar Nyombi; Michael Omondi; Julian B Mushi; Eileen S Lirhunde; John A Bartlett
Journal:  AIDS Behav       Date:  2018-05

5.  Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.

Authors:  J F G Monteiro; D J Escudero; C Weinreb; T Flanigan; S Galea; S R Friedman; B D L Marshall
Journal:  Epidemiol Infect       Date:  2016-01-12       Impact factor: 2.451

6.  Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses.

Authors:  Jérémie Prévost; Daria Zoubchenok; Jonathan Richard; Maxime Veillette; Beatriz Pacheco; Mathieu Coutu; Nathalie Brassard; Matthew S Parsons; Kiat Ruxrungtham; Torsak Bunupuradah; Sodsai Tovanabutra; Kwan-Ki Hwang; M Anthony Moody; Barton F Haynes; Mattia Bonsignori; Joseph Sodroski; Daniel E Kaufmann; George M Shaw; Agnès L Chenine; Andrés Finzi
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

7.  Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire.

Authors:  Albert Minga; Christine Danel; Yao Abo; Lambert Dohoun; Dominique Bonard; Ali Coulibaly; Julien Duvignac; François Dabis; Roger Salamon; Xavier Anglaret
Journal:  Bull World Health Organ       Date:  2007-02       Impact factor: 9.408

8.  HLA Class I Alleles Associated with Mortality in Thai Military Recruits with HIV-1 CRF01_AE Infection.

Authors:  Rajesh T Gandhi; Ronald J Bosch; Ram Rangsin; Thippawan Chuenchitra; Narongrid Sirisopana; Jerome H Kim; Merlin L Robb; Sasijit Vejbaesya; Robert M Paris; Kenrad E Nelson
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-18       Impact factor: 2.205

9.  Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.

Authors:  Jim Todd; Judith R Glynn; Milly Marston; Tom Lutalo; Sam Biraro; Wambura Mwita; Vinai Suriyanon; Ram Rangsin; Kenrad E Nelson; Pam Sonnenberg; Dan Fitzgerald; Etienne Karita; Basia Zaba
Journal:  AIDS       Date:  2007-11       Impact factor: 4.177

10.  Estimating 'net' HIV-related mortality and the importance of background mortality rates.

Authors:  Milly Marston; Jim Todd; Judith R Glynn; Kenrad E Nelson; Ram Rangsin; Tom Lutalo; Mark Urassa; Sam Biraro; Lieve Van der Paal; Pam Sonnenberg; Basia Zaba
Journal:  AIDS       Date:  2007-11       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.